Introduction Type 2 diabetes mellitus (DM) is an important factor that is associated with increased cardiovascular morbidity, producing disorders in different devices and systems whose mechanisms are not entirely known. This study was conducted in order to understand the evolution of aerobic capacity and the different cardiovascular risk factors (CVRF) in diabetic patients compared to non-diabetic patients. Methodology Prospective observational study. A total of 301 patients were included consecutively in a conventional cardiac rehabilitation program from January 2017 to March 2020, after one month of having had acute coronary syndrome, phase II of which lasted 2 months, who had an analysis, ergometry with spire gas analysis, and anthropometric characteristics were included. Those who had signs of ischemia in ergometry were excluded from the study. The tests were conducted as recommended by the ATS/ACCP. Results 301 patients were included, with an average age of 57.6±9.1 years, diabetics 92 (30,6%), LVEF average 56.9±9.6%, women 13.6%. Among the basal characteristics, diabetic patients had the highest prevalence of dyslipemia (89.1% vs 68.4% p s <0.001), HTA (62% vs 47.8% p x 0.03) and lower FEVI (55.1±10.26 vs 57.8±8.9 p-0.03), in addition to lower peak oxygen consumption (VO2 ml/kg/min) (18.8±5.0 vs 22.9±6.3 p-<0.001); DM being an independent predictor to obtain a lower VO2 with an OR 1.25 [IC (95%) 1.31–1.19 p<0.001] (Table 1). At the end of Phase II, both groups gained better control of CVRF (Table 2) including an improvement in VO2; but in the DM group the gain rate was significantly lower (0.08±0.14 Vs 0.13±0.17 p=0.02). In phase III (average follow-up 7.3 months) the benefits in the control of CVRF (Table 2) were maintained in both groups with the highest rate of increase in VO2 in patients with DM (0.07±0.2 Vs 0.02±0.13 p=0.05) (Image 1). Conclusions In our study, patients with DM undergoing an RHC program achieve better control of FRCV and aerobic capacity in a similar way to non-diabetic patients, which is maintained at 7 months of follow-up in phase III, although initially the aerobic capacity gain in diabetics is slower, achieve a higher increase in VO2 in Phase III. Funding Acknowledgement Type of funding sources: None.
Introduction To determine the aerobic capacity and the cardiopulmonary response to exercise is an important tool to assess functional capacity and a pronostic factor in patients with coronary artery disease (CAD). Maximal oxygen uptake (VO2) is considered the gold standard for measuring aerobic capacity, and a maximal graded exercise test is required for its direct measurement. Nevertheless, it requires long duration sessions, qualified medical personal and expensive equipment in order to perform it. These are the main reasons why its use is not widely spread in daily clinical practice and more accessible tests are needed. The aim of this study is to determine if we can predict the VO2 in patients with CAD, depending on basal characteristics of the patient. Objective To develop an equation to predict VO2 based on the 6-minute walk test (6MWT), basal characteristics and the presence of cardiovascular risk factors in patients with CAD and preserved left ventricular ejection fraction (LVEF). Methods We performed a cross-sectional prospective study with 202 patients with CAD and preserved LVEF, who were consecutively included in a conventional cardiac rehabilitation programme from March of 2019 to March of 2020 and underwent a 6-minute walk distance test and an ergoespirometry. The presence of cardiovascular risk factors, comorbidities and anthropometric variables were also evaluated. The tests were performed following ATS recommendations. The predictive equation for VO2 was obtained with a multivariate regression analysis. To assess the fit of the predictive model, we used conventional linear regression models according to the coefficient of determination (R2). A P value <0,05 was statistically significant. Results A total of 202 patients were analysed. The mean age was 57,5±9,3 years, mean LVEF was 61,2±6,14%, 13,4% were female, 54,4% arterial hypertension, 30,2% with diabetes, 76,7% dyslipidemia, 36,1% obese, 6,4% with peripheric artery disease, 9,4% with pulmonary disease. Correlations of the mentioned characteristics and the 6MWT with VO2 were statistically significant (p<0,001). Objectively measured VO2 had a significant correlation with age, gender, type II diabetes mellitus, BMI and 6MWT. Multiple regression analysis revealed the following VO2 prediction equation: 32,590-[2,784x gender (0=male/1=female)]-(0,177x age)-(2,756x DM (0=ausence/1= presence)]+(0,027x6MWT)-(0,468xBMI). There was acceptable correlation between measured and predicted VO2 max (R2=0,6). There were not stadistically significant differences between measured VO2 max by ergoespirometry and predicted VO2 max by our equation (22,52±5,82 vs 23,02±4,28, p=0,057). Conclusions Our study provides an VO2 prediction equation based on the demographical characteristics, the presence of cardiovascular risk factors and the results in the 6MWT in patients with CAD, which might be used as an alternative in the case of unavailability of an ergoespirometry. Funding Acknowledgement Type of funding sources: None.
A 66-year-old man presented with 2 asymptomatic ulcerations on the right cheek (Figure 1). These began as enlarging
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.